|
01/27/05
-- Taking steroids is a definite no-no for human athletes, but treating
plants with steroids could offer performance enhancement of a more desirable
nature by boosting the biomass and seed yields of crops. Unfortunately,
plant steroids are complex, expensive chemicals, and the biological
mechanisms by which they alter plant growth and development have remained
largely a mystery.
Now, however,
two research articles by Howard Hughes Medical Institute investigator Joanne
Chory and her colleagues open a new pathway to understanding how plant
steroids work at the molecular level. The discoveries made by Chory's team
may one day lead to less expensive ways to trigger growth enhancement of
plants.
"The common
theme of these two articles is that we are now beginning to unravel the
molecular mechanisms by which steroid hormones regulate gene expression in
plants," said Chory, who is at The Salk Institute for Biological Studies.
The first
study reveals how plant steroid hormones, called brassinosteroids, plug into
and activate receptor proteins on the surface of plant cells. Receptor
activation is the first step in triggering processes, such as growth,
development, the stress response and senescence -- the deterioration of
plants at the end of a growing season. In a second study, the researchers
identified and clarified the function of specific transcription factors,
which are proteins that regulate genes involved in the cell's response to
steroids.
The
researchers reported their findings in articles published in the January 13,
2005, issue of the journal Nature and in the January 28, 2005, issue of the
journal Cell. Chory and her Salk Institute colleagues collaborated on the
studies published in Nature with Japanese researchers at Kyushu University
and the RIKEN research institute. They collaborated with researchers from
RIKEN on the studies published in Cell.
"Before this
work we had a genetic model for what we thought was going on with steroid
signaling in plants," said Chory. This model resulted from studying the
effects of mutations in genes that were believed to be part of the steroid
signaling machinery.
Those
experiments hinted that one important steroid-related gene coded for a
receptor protein called BRI1 that bound to the cell membrane. Their
experiments indicated that another protein, a kinase called BIN2, appeared
to act negatively in the steroid pathway to modify BES1 and BZR1 proteins,
which targeted these proteins for turnover. In the presence of the steroids,
BIN2 becomes inactivated by an unknown mechanism, thereby allowing BES1 and
BZR1 to accumulate in the nucleus of the plant cell.
"Although
we've known about BRI1 for almost eight years, we hadn't shown that it was
actually a steroid receptor and not just part of a bigger complex," said
Chory. To determine whether BRI1 was indeed the steroid receptor, co-author
Hideharu Seto of RIKEN constructed synthetic versions of a functional
steroid molecule that carried a telltale chemical tag. This synthetic
steroid could also form a tight chemical bond with its natural target
molecule when exposed to ultraviolet light. Experiments done in the Chory
lab demonstrated that this synthetic steroid interacted directly with BRI1
and allowed her team to define a small region of BRI1 that is outside of the
cell as the part of the molecule responsible for steroid binding. "These
experiments enabled us to show definitively that BRI1 was actually binding
to the steroid itself and wasn't just part of a bigger complex", said Chory.
Chory said
that demonstrating that the steroid binds to BRI1 will open the way to new
studies of the structural details of the interaction. "We will aim to obtain
a three-dimensional structure of this receptor both with and without the
steroid attached," she said. "And once we do that, we can begin to
understand how this binding transmits signals inside the cell."
In the
article published in Cell, Chory and her colleagues discovered important new
details about how steroids transmit a chemical signal to the interior of
plant cells. "Our genetic studies had identified the proteins BES1 and the
similar protein BZR1 as two that accumulate in the nucleus as a result of
steroid action," said Chory. However, despite the fact that the proteins
were in a location and in a form that suggested they could regulate gene
activity, they did not appear to possess any of the known structures found
in transcription factors seen in either plant or animal cells, said Chory.
But the researchers' experiments showed that
BES1 does, indeed, bind to and interact with DNA in a way that one would
expect if it were a transcription factor. The experiments also revealed that
BES1 joins with another
transcription
factor called BIM1 to activate genes known to be regulated by steroid
hormones.
"So, in these
two papers we have established a precise function for proteins that were
known from genetic experiments to be important in steroid signaling, but we
didn't know exactly what they were doing," concluded Chory.
"These
findings open the way to understanding the molecular mechanism of one of the
key plant growth hormones; and this will offer the prospect for actively
increasing the biomass and yield in crop plants," she said. "Understanding
this mechanism is important because, although the steroids themselves do
affect plants, they are prohibitively expensive. If we can find simpler ways
of manipulating these biosynthetic response pathways in plants, it could
have a very significant impact on crop yields, as well plant response to
stress and to senescence programs," said Chory.
Source: Howard Hughes Medical Institute |